189.30
1.25 (0.66%)
| Previous Close | 188.05 |
| Volume | 582,943 |
| Price / Sales | 22.42 |
| Price / Book | 23.58 |
| 52 Weeks Range |
| Profit Margin | -54.98% |
| Operating Margin (TTM) | -44.79% |
| Diluted EPS (TTM) | -3.25 |
| Quarterly Revenue Growth (YOY) | 23.20% |
| Total Debt/Equity (MRQ) | 18.25% |
| Current Ratio (MRQ) | 4.51 |
| Operating Cash Flow (TTM) | -56.11 M |
| Levered Free Cash Flow (TTM) | -16.89 M |
| Return on Assets (TTM) | -15.04% |
| Return on Equity (TTM) | -38.22% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Twist Bioscience Corporation | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -4.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | -0.13 |
|
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company’s proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 1.98% |
| % Held by Institutions | 115.15% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| CHO DENNIS | - | 165.83 | -348 | -57,709 |
| GREEN PAULA | - | 165.83 | -294 | -48,754 |
| LEPROUST EMILY M. | - | 174.93 | -6,890 | -1,237,263 |
| Aggregate Net Quantity | -7,532 | |||
| Aggregate Net Value ($) | -1,343,726 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 170.38 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| LEPROUST EMILY M. | Officer | 24 Sep 2026 | Automatic sell (-) | 5,203 | 184.03 | 957,508 |
| GREEN PAULA | Officer | 21 Sep 2026 | Sell (-) | 294 | 165.83 | 48,754 |
| LEPROUST EMILY M. | Officer | 21 Sep 2026 | Sell (-) | 1,687 | 165.83 | 279,755 |
| CHO DENNIS | Officer | 21 Sep 2026 | Sell (-) | 348 | 165.83 | 57,709 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |